anmelden
SMI Expanded
1.972,28
PKT
-10,97
PKT
-0,55
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu SMI Expanded-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 23.11.22 | ams-OSRAM Hold | Jefferies & Company Inc. | |
| 23.11.22 | UBS Hold | Jefferies & Company Inc. | |
| 23.11.22 | UBS Neutral | JP Morgan Chase & Co. | |
| 23.11.22 | Nestlé Buy | Goldman Sachs Group Inc. | |
| 23.11.22 | Swiss Re Sell | Goldman Sachs Group Inc. | |
| 22.11.22 | Novartis Sell | Deutsche Bank AG | |
| 22.11.22 | ams-OSRAM Neutral | Credit Suisse Group | |
| 22.11.22 | Swiss Re Equal Weight | Barclays Capital | |
| 22.11.22 | Zurich Insurance Overweight | Barclays Capital | |
| 22.11.22 | Richemont Overweight | Barclays Capital | |
| 21.11.22 | Givaudan Sell | UBS AG | |
| 21.11.22 | ABB (Asea Brown Boveri) Outperform | RBC Capital Markets | |
| 21.11.22 | Richemont Buy | Deutsche Bank AG | |
| 21.11.22 | Richemont Overweight | JP Morgan Chase & Co. | |
| 21.11.22 | UBS Underweight | Barclays Capital | |
| 21.11.22 | Nestlé Overweight | Barclays Capital | |
| 17.11.22 | Zurich Insurance Hold | Jefferies & Company Inc. | |
| 17.11.22 | Richemont Overweight | JP Morgan Chase & Co. | |
| 16.11.22 | Zurich Insurance Neutral | Goldman Sachs Group Inc. | |
| 16.11.22 | Zurich Insurance Buy | UBS AG | |
| 16.11.22 | Givaudan Underperform | Bernstein Research | |
| 16.11.22 | Zurich Insurance Overweight | JP Morgan Chase & Co. | |
| 15.11.22 | UBS Neutral | JP Morgan Chase & Co. | |
| 15.11.22 | Roche Hold | Deutsche Bank AG | |
| 15.11.22 | DocMorris Sell | Deutsche Bank AG | |
| 14.11.22 | Richemont Neutral | Credit Suisse Group | |
| 14.11.22 | Roche Outperform | Credit Suisse Group | |
| 14.11.22 | UBS Hold | Jefferies & Company Inc. | |
| 14.11.22 | Richemont Buy | UBS AG | |
| 14.11.22 | Roche Neutral | JP Morgan Chase & Co. | |
| 14.11.22 | Roche Overweight | Barclays Capital | |
| 14.11.22 | Roche Buy | Jefferies & Company Inc. | |
| 14.11.22 | Roche Neutral | UBS AG | |
| 14.11.22 | Roche Outperform | Bernstein Research | |
| 14.11.22 | Richemont Conviction Buy List | Goldman Sachs Group Inc. | |
| 14.11.22 | Richemont Outperform | RBC Capital Markets | |
| 11.11.22 | Richemont Overweight | JP Morgan Chase & Co. | |
| 11.11.22 | Richemont Buy | UBS AG | |
| 11.11.22 | Richemont Overweight | Barclays Capital | |
| 11.11.22 | Richemont Conviction Buy List | Goldman Sachs Group Inc. |
